SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
2.640
+0.120 (4.76%)
At close: Mar 9, 2026, 4:00 PM EDT
2.600
-0.040 (-1.52%)
After-hours: Mar 9, 2026, 5:49 PM EDT
SeaStar Medical Holding Revenue
SeaStar Medical Holding had revenue of $183.00K in the quarter ending September 30, 2025, with 169.12% growth. This brings the company's revenue in the last twelve months to $881.00K, up 1,195.59% year-over-year. In the year 2024, SeaStar Medical Holding had annual revenue of $135.00K.
Revenue (ttm)
$881.00K
Revenue Growth
+1,195.59%
P/S Ratio
10.80
Revenue / Employee
$46,368
Employees
19
Market Cap
9.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 135.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bolt Biotherapeutics | 5.20M |
| CollPlant Biotechnologies | 2.48M |
| Longeveron | 1.44M |
| Iterum Therapeutics | 390.00K |
| Cardio Diagnostics Holdings | 15.78K |
| Alaunos Therapeutics | 6.00K |
ICU News
- 11 hours ago - SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th - GlobeNewsWire
- 4 days ago - SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI - GlobeNewsWire
- 4 weeks ago - SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI) - GlobeNewsWire
- 5 weeks ago - SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference - GlobeNewsWire
- 2 months ago - SeaStar Medical Announces 2026 Milestones - GlobeNewsWire
- 2 months ago - SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference - GlobeNewsWire
- 2 months ago - SeaStar Medical Announces 1-for-10 Reverse Split - GlobeNewsWire
- 3 months ago - SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI - GlobeNewsWire